Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) EBT Margin (2016 - 2026)

Champions Oncology has reported EBT Margin over the past 17 years, most recently at 1.43% for Q1 2026.

  • For Q1 2026, EBT Margin fell 2795.0% year-over-year to 1.43%; the TTM value through Jan 2026 reached 4.14%, down 1506.0%, while the annual FY2025 figure was 8.12%, 2269.0% up from the prior year.
  • EBT Margin for Q1 2026 was 1.43% at Champions Oncology, down from 1.7% in the prior quarter.
  • Over five years, EBT Margin peaked at 26.52% in Q1 2025 and troughed at 20.96% in Q1 2024.
  • A 5-year average of 4.41% and a median of 2.2% in 2022 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: skyrocketed 4747bps in 2025 and later plummeted -2795bps in 2026.
  • Year by year, EBT Margin stood at 0.01% in 2022, then crashed by -127001bps to 17.8% in 2023, then skyrocketed by 131bps to 5.48% in 2024, then tumbled by -69bps to 1.7% in 2025, then crashed by -184bps to 1.43% in 2026.
  • Business Quant data shows EBT Margin for CSBR at 1.43% in Q1 2026, 1.7% in Q4 2025, and 3.23% in Q3 2025.